Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd
600721.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.85B
Close$
Share Statistics
| Market cap | $4.85 Billion |
|---|---|
| Enterprise Value | $4.89 Billion |
| Dividend Yield | $0.04 (0.32%) |
| Earnings per Share | $0.11 |
| Beta | -0.22 |
| Outstanding Shares | 384,547,635 |
Return
| Return on Equity | 3.74% |
|---|---|
| Return on Assets | 2.81% |
| Return on Invested Capital | 3.96% |
Valuation & Multiples
| P/E Ratio | 161.87 |
|---|---|
| PEG | 229.79 |
| Price to Sales | - |
| Price to Book Ratio | 6.31 |
| Enterprise Value to Revenue | 14.23 |
| Enterprise Value to EBIT | 145.21 |
| Enterprise Value to Net Income | 163 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.13 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd
672 employees
CEO: Hui Huang Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd conducts its operations across a diverse range of business sectors. Its core activities encompass pharmaceutical research and development, clinical studies, and the field of biomedicine, alongside...